Disease-specific gene repositioning in breast cancer

Karen J. Meaburn, Prabhakar R. Gudla, Sameena Khan, Stephen J. Lockett, Tom Misteli
J. Cell Biol. Dec 1, 2009
… …Normal Absence of cancer; 56 y BioChain T2234086 5 microm N6 Normal NAT; 50 y BioChain TMA core A2 4 microm N7 Normal…C7 IDC TMN stage T4N3M1; 50 y BioChain TMA core C1 4 microm C8 IDC… …

Leave a Reply